|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/10 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 3250591 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16703030.3 |
| Date of filing the European patent application | 2016-01-25 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-12 |
| (46) | Date of publication of the claims translation | 2025-12-29 |
| (86) | Number | PCT/US2016/014720 |
| Date | 2016-01-25 |
| (87) | Number | WO 2016/123019 |
| Date | 2016-08-04 |
| (30) | Number | Date | Country code |
| 201562107581 P | 2015-01-26 | US | |
| 201562161356 P | 2015-05-14 | US | |
| 201562245703 P | 2015-10-23 | US |
| (72) |
KYRATSOUS, Christos , US
OLSON, William , US
MASON, Peter , US
STAHL, Neil , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Žmogaus antikūnai prieš Ebolos viruso glikoproteiną |
| HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN |
| Payment date | Validity (years) | Amount | |
| 2026-01-02 | 11 | 289.00 EUR |
| 2027-01-25 |